These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16286877)

  • 1. Weakness in the ICU: Guillain-Barré syndrome, myasthenia gravis, and critical illness polyneuropathy/myopathy.
    Green DM
    Neurologist; 2005 Nov; 11(6):338-47. PubMed ID: 16286877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular disorders in the intensive care unit.
    Marinelli WA; Leatherman JW
    Crit Care Clin; 2002 Oct; 18(4):915-29, x. PubMed ID: 12418447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuromuscular abnormalities in critical illness].
    Amaya Villar R; Garnacho-Montero J; Rincón Ferrari MD
    Med Intensiva; 2009 Apr; 33(3):123-33. PubMed ID: 19406085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome following thoracic spinal cord trauma.
    Scozzafava J; Jickling G; Jhamandas JH; Jacka MJ
    Can J Anaesth; 2008 Jul; 55(7):441-6. PubMed ID: 18591702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Getting Rid of Weakness in the ICU: An Updated Approach to the Acute Management of Myasthenia Gravis and Guillain-Barré Syndrome.
    Lizarraga AA; Lizarraga KJ; Benatar M
    Semin Neurol; 2016 Dec; 36(6):615-624. PubMed ID: 27907966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Catastrophic neuromuscular diseases].
    Muñoz Blanco JL
    Neurologia; 2010 Oct; 25 Suppl 1():37-45. PubMed ID: 21129596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Guillain-Barré syndrome and myasthenia gravis.
    Hsieh MY; Chan OW; Lin JJ; Lin KL; Hsia SH; Wang HS; Chiu CH
    Brain Dev; 2013 Oct; 35(9):865-9. PubMed ID: 23177060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High doses of immunoglobulin G in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome].
    Lavrnić D; Romić M; Kacar A; Stojanović-Rakocević V; Stević Z; Vujić A; Basta I; Marjanović I; Bogdanović G; Apostolski S
    Vojnosanit Pregl; 2006 Jan; 63(1):37-42. PubMed ID: 16471247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of critical illness on axonal loss in Guillain-Barré syndrome.
    Ho D; Thakur K; Gorson KC; Ropper AH
    Muscle Nerve; 2009 Jan; 39(1):10-5. PubMed ID: 19086065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICU-acquired weakness.
    Schweickert WD; Hall J
    Chest; 2007 May; 131(5):1541-9. PubMed ID: 17494803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the management of Guillain-Barré syndrome.
    Green DM
    Curr Neurol Neurosci Rep; 2002 Nov; 2(6):541-8. PubMed ID: 12359110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
    Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
    J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis and Guillain-Barré cooccurrence syndrome.
    Zhang J; Niu S; Wang Y; Hu W
    Am J Emerg Med; 2013 Aug; 31(8):1264-7. PubMed ID: 23809092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular Disorders in the Intensive Care Unit.
    Birch TB
    Continuum (Minneap Minn); 2021 Oct; 27(5):1344-1364. PubMed ID: 34618763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Neuromuscular Disorders in the Pediatric Intensive Care Unit.
    Harrar DB; Darras BT; Ghosh PS
    J Child Neurol; 2020 Jan; 35(1):17-24. PubMed ID: 31502491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes.
    Latronico N; Rasulo FA; Eikermann M; Piva S
    Crit Care; 2023 Nov; 27(1):439. PubMed ID: 37957759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis.
    Haupt WF; Rosenow F; van der Ven C; Birkmann C
    Ther Apher; 2000 Jun; 4(3):195-7. PubMed ID: 10910018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action.
    Shahrizaila N; Yuki N
    Expert Opin Pharmacother; 2011 Jul; 12(10):1551-60. PubMed ID: 21473704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical consequences of neuromuscular impairments in critically ill patients].
    Mesejo A; Pérez-Sancho E; Moreno E
    Nutr Hosp; 2006 May; 21 Suppl 3():104-13. PubMed ID: 16768037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.